Banque Cantonale Vaudoise’s ResMed RMD Stock Holding History

Banque Cantonale Vaudoise’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$921	Sell	4,722 -2,971	-39%	-$616K	﹤0.01%	460
2026 Q1	$1.73M	Buy	+7,693	New	+$1.92M	0.07%	278
2025 Q3	–	Sell	-4,235	Closed	-$1.09M	–	854
2025 Q2	$1.09M	Buy	4,235 +2,664	+170%	+$635K	0.04%	344
2025 Q1	$352K	Buy	+1,571	New	+$367K	0.02%	496
2024 Q3	–	Sell	-1,641	Closed	-$314K	–	968
2024 Q2	$314K	Buy	+1,641	New	+$333K	0.01%	514
2024 Q1	–	Sell	-1,464	Closed	-$252K	–	1060
2023 Q4	$252K	Sell	1,464 -700	-32%	-$108K	0.01%	546
2023 Q3	$321K	Sell	2,164 -136	-6%	-$24.6K	0.02%	565
2023 Q2	$502K	Sell	2,300 -2,200	-49%	-$490K	0.02%	486
2023 Q1	$985K	Hold	4,500	–	–	0.05%	310
2022 Q4	$936K	Hold	4,500	–	–	0.05%	312
2022 Q3	$982K	Hold	4,500	–	–	0.06%	332
2022 Q2	$944K	Sell	4,500 -200	-4%	-$42.6K	0.05%	358
2022 Q1	$1.14M	Sell	4,700 -2,472	-34%	-$598K	0.05%	361
2021 Q4	$1.87M	Sell	7,172 -928	-11%	-$241K	0.07%	254
2021 Q3	$2.13M	Buy	8,100 +3,200	+65%	+$875K	0.09%	216
2021 Q2	$1.21M	Sell	4,900 -700	-13%	-$147K	0.05%	380
2021 Q1	$1.09M	Hold	5,600	–	–	0.06%	352
2020 Q4	$1.19M	Hold	5,600	–	–	0.07%	263
2020 Q3	$960K	Sell	5,600 -3,800	-40%	-$702K	0.06%	269
2020 Q2	$1.8M	Sell	9,400 -8,700	-48%	-$1.42M	0.13%	157
2020 Q1	$2.67M	Hold	18,100	–	–	0.23%	89
2019 Q4	$2.81M	Buy	+18,100	New	+$2.61M	0.19%	115

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Banque Cantonale Vaudoise's RMD Position: Q2 2026 in Review

Banque Cantonale Vaudoise reduced its ResMed (RMD) stake by 39% in Q2 2026, selling an estimated $616K and leaving 4,722 shares worth $921. The position accounts for ﹤0.01% of the portfolio, ranked #460.

Banque Cantonale Vaudoise first reported a position in RMD in Q4 2019 and has held it in 22 quarters since. The position peaked at $2.81M in Q4 2019. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

Banque Cantonale Vaudoise held 4,722 shares of ResMed worth $921 as of Q2 2026.
Banque Cantonale Vaudoise sold 2,971 ResMed shares in Q2 2026, an estimated $616K.
ResMed made up ﹤0.01% of Banque Cantonale Vaudoise's portfolio in Q2 2026, its #460 holding.
Banque Cantonale Vaudoise first reported a position in ResMed in Q4 2019 and has held it in 22 quarters since.
Banque Cantonale Vaudoise's ResMed position peaked at $2.81M in Q4 2019.
887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Banque Cantonale Vaudoise's 13F filing for Q2 2026, filed 31 Jul 2026.